MiniMed Group Inc (NASDAQ:MMED) Stock Short Interest Declines 52.8%

MiniMed Group Inc (NASDAQ:MMED – Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 30th, there was short interest totaling 9,813,734 shares, a decrease of 52.8% from the October 15th total of 20,793,160 shares. Approximately 3.5% of the company’s stock are short sold. Based on an average daily trading volume, of 10,245,967 shares, the days-to-cover ratio is presently 1.0 days.

Institutional Trading of MiniMed Group

Large investors have recently bought and sold shares of the company. Parkside Financial Bank & Trust purchased a new position in shares of MiniMed Group during the 2nd quarter valued at $28,000. Legal & General Group Plc purchased a new stake in MiniMed Group in the 2nd quarter worth about $91,000. State of Wyoming bought a new stake in MiniMed Group in the 3rd quarter valued at about $167,000. State of Alaska Department of Revenue bought a new stake in MiniMed Group in the 3rd quarter valued at about $227,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in MiniMed Group during the second quarter valued at about $185,000.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on MMED shares. BTIG Research lifted their price objective on shares of MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, September 1st. Citigroup upped their target price on shares of MiniMed Group from $23.00 to $26.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Weiss Ratings upgraded shares of MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a report on Wednesday, September 9th. Bank of America raised their price target on shares of MiniMed Group from $24.00 to $28.00 and gave the company a “buy” rating in a research report on Wednesday, September 2nd. Finally, Wells Fargo & Company boosted their price target on shares of MiniMed Group from $22.00 to $26.00 and gave the stock an “overweight” rating in a report on Wednesday, September 2nd. Fourteen investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $24.12.

View Our Latest Analysis on MMED

MiniMed Group Price Performance

Shares of MiniMed Group stock traded up $0.11 during trading hours on Friday, hitting $17.99. 5,376,894 shares of the company’s stock traded hands, compared to its average volume of 8,750,697. The stock has a market capitalization of $5.06 billion and a price-to-earnings ratio of -26.46. MiniMed Group has a 12-month low of $10.65 and a 12-month high of $24.43. The company has a fifty day simple moving average of $19.61 and a 200-day simple moving average of $16.73.

About MiniMed Group

(Get Free Report)

MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery. The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.

Featured Stories

Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.